Full history for every metric is available with a Kvantra account
Key financial summary
Financials in SGDTTM unavailable because four recent quarterly reports are not available| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | SGD m | - | - | - | - | - | - | - |
| Operating profit | SGD m | - | ||||||
| Net profit | SGD m | - | - | - | - | - | - | - |
| EPS reported | SGD | - | ||||||
| Operating cashflow per share | SGD | - | ||||||
| Capex per share | SGD | - | ||||||
| FCF per share | SGD | - | ||||||
| Free cash flow | SGD m | - | ||||||
| Net debt | SGD m | - | ||||||
| Book value equity | SGD m | - | ||||||
| Book value per share | SGD | - | ||||||
| Number of shares | m | - | ||||||
| DPS (TTM paid) | SGD | - |
Financial summary
Financials in SGDTTM unavailable because four recent quarterly reports are not available| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | ||||||
| P/B LTM | x | - | ||||||
| P/S LTM | x | - | ||||||
| P/FCF LTM | x | - | ||||||
| EV/EBITDA LTM | x | - | ||||||
| EV/Sales LTM | x | - | ||||||
| Earnings Yield LTM | % | - | ||||||
| FCF Yield | % | - | ||||||
| Quality | ||||||||
| ROE | % | - | ||||||
| ROIC | % | - | ||||||
| Operating margin | % | - | ||||||
| Gross margin | % | - | ||||||
| FCF/Sales | % | - | ||||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | ||||||
| Sales Growth YoY | % | - | ||||||
| Net Income Growth YoY | % | - | ||||||
| FCF Growth | % | - | ||||||
| Operating Profit Growth | % | - | ||||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | ||||||
| Dividend Growth | % | - | ||||||
| Payout Ratio | % | - | ||||||
| FCF/Debt | x | - | ||||||
| Net Debt/EBITDA | x | - | ||||||
| EBIT/Net interest | x | - | ||||||
| Net debt/market cap | % | - | ||||||
| Net debt/Equity | x | - | ||||||
| Gross debt/equity | x | - | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Accrelist Ltd. is an investment holding company, which engages in medical aesthetics and fintech. It operates through the following segments: Mechanical Business Unit (MBU), Aesthetic Medical Services (AMS), and Others. The MBU segment provides mold design and fabrication services for automotive and computer peripherals, consumer electronics, and household appliances. The AMS segment offers a range of services related to aesthetic enhancements. The Others segment refers to engineering support services, supply chain management, and financial services. The company was founded on March 6, 1986 and is headquartered in Singapore.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Accrelist Ltd. is an investment holding company, which engages in medical aesthetics and fintech. It operates through the following segments: Mechanical Business Unit (MBU), Aesthetic Medical Services (AMS), and Others. The MBU segment provides mold design and fabrication services for automotive and computer peripherals, consumer electronics, and household appliances. The AMS segment offers a range of services related to aesthetic enhancements. The Others segment refers to engineering support services, supply chain management, and financial services. The company was founded on March 6, 1986 and is headquartered in Singapore.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free